Nature’s Sunshine targets $1B in sales and 15% EBITDA margin while cutting 2026 sales outlook to $490M-$500M (NASDAQ:NATR)August 7, 2026
Nature’s Sunshine targets $1B in sales and 15% EBITDA margin while cutting 2026 sales outlook to $490M-$500M (NASDAQ:NATR)August 7, 2026
Arteris raises FY 2026 revenue outlook to $95M-$98M as ACV plus royalties targets $102M-$106M (NASDAQ:AIP)August 7, 2026
